NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 356 filers reported holding NEKTAR THERAPEUTICS in Q1 2019. The put-call ratio across all filers is 1.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $32,000 | -98.3% | 1,612 | -98.5% | 0.01% | -98.4% |
| Q4 2020 | $1,832,000 | +13.3% | 107,736 | +16.0% | 0.32% | +3.9% |
| Q3 2020 | $1,617,000 | +3.0% | 92,836 | +29.2% | 0.31% | -10.8% |
| Q2 2020 | $1,570,000 | +53.2% | 71,836 | +45.6% | 0.34% | +28.5% |
| Q1 2020 | $1,025,000 | +75.5% | 49,336 | +86.9% | 0.27% | +62.8% |
| Q4 2019 | $584,000 | +16.6% | 26,400 | -11.6% | 0.16% | -6.3% |
| Q3 2019 | $501,000 | +21.0% | 29,874 | +125.1% | 0.18% | +0.6% |
| Q2 2019 | $414,000 | +24.0% | 13,274 | +28.0% | 0.17% | +22.5% |
| Q1 2019 | $334,000 | +16.8% | 10,374 | +46.2% | 0.14% | -4.1% |
| Q4 2018 | $286,000 | +13.9% | 7,098 | +7.6% | 0.15% | +5.7% |
| Q3 2018 | $251,000 | – | 6,598 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 432,952 | $1,385,000 | 0.91% |
| GREAT POINT PARTNERS LLC | 447,820 | $1,433,000 | 0.34% |
| Birchview Capital, LP | 128,000 | $410,000 | 0.29% |
| Edgestream Partners, L.P. | 1,047,636 | $3,352,000 | 0.26% |
| Rhenman & Partners Asset Management AB | 550,000 | $2,068,000 | 0.22% |
| CM Management, LLC | 50,000 | $160,000 | 0.18% |
| TANG CAPITAL MANAGEMENT LLC | 430,037 | $1,376,000 | 0.17% |
| PDT Partners, LLC | 307,953 | $985,000 | 0.15% |
| Virtus ETF Advisers LLC | 72,018 | $230,000 | 0.09% |
| ALGERT GLOBAL LLC | 476,412 | $1,525,000 | 0.09% |